2007
DOI: 10.1002/art.22748
|View full text |Cite
|
Sign up to set email alerts
|

Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: Identification of the interleukin‐7 signaling pathway in tissues with lymphoid neogenesis

Abstract: Objective. In ϳ25% of synovial tissues from rheumatoid arthritis (RA) patients, infiltrates of T cells, B cells, and follicular dendritic cells (FDCs) are spatially organized into structures resembling lymph nodes with germinal centers. The remainder of the tissues lack FDCs and show either a diffuse or an aggregated T cell and B cell infiltrate. To gain more insight into this specific disease process, we sought to identify the genes expressed in RA tissues with ectopic lymphoid structures.Methods. Gene expres… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
147
1

Year Published

2007
2007
2017
2017

Publication Types

Select...
8
1
1

Relationship

4
6

Authors

Journals

citations
Cited by 151 publications
(157 citation statements)
references
References 50 publications
9
147
1
Order By: Relevance
“…Notably, ELFs are described at all stages of the disease and include patients with early active disease who have not received biological agents, patents with more progressive forms of rheumatoid arthritis, and those that have already received biological intervention 43, 112, 113. Although the mechanisms contributing the development of this form of pathology are largely unclear, ELFs in rheumatoid arthritis are associated with heightened synovial expression of CXCL13, CCL21, CCL19 and CXCL12, and cytokines LT α 1 β 2 and IL‐7 21, 44, 114, 115. Importantly, these structures correlate with disease severity and are associated with local T‐cell priming and autoantibody production 43, 116, 117, 118.…”
Section: Elfs As Perpetuators Of Inflammation‐driven Pathologymentioning
confidence: 99%
“…Notably, ELFs are described at all stages of the disease and include patients with early active disease who have not received biological agents, patents with more progressive forms of rheumatoid arthritis, and those that have already received biological intervention 43, 112, 113. Although the mechanisms contributing the development of this form of pathology are largely unclear, ELFs in rheumatoid arthritis are associated with heightened synovial expression of CXCL13, CCL21, CCL19 and CXCL12, and cytokines LT α 1 β 2 and IL‐7 21, 44, 114, 115. Importantly, these structures correlate with disease severity and are associated with local T‐cell priming and autoantibody production 43, 116, 117, 118.…”
Section: Elfs As Perpetuators Of Inflammation‐driven Pathologymentioning
confidence: 99%
“…38). It is thought that functional DC/T cell interaction can take place locally (39,40), and the perivascular region may act as a site for cell activation (41). Intriguingly, surgical removal of cartilage in RA patients led to reduced inflammation and suppression of functional differentiation of DCs in the synovium (42).…”
Section: Maturationmentioning
confidence: 99%
“…Chemokines (CXCL13, CCL19, and CCL21) and cytokines (lyphotoxin ␤, LTb) play a central role in the development, organization, and maintenance of lymphoid architecture (34) and are produced locally during RA synovitis (15,23,35). To understand why synovial lymphoid neogenesis only occasionally progresses toward differentiated GC-reactions, we assessed the synovial expression of these factors by quantitative RT-PCR.…”
Section: Differential Chemokine Expression Profile Of Synovial Lymphomentioning
confidence: 99%